Literature DB >> 26414644

Radiofrequency ablation of hepatocellular carcinoma: Mono or multipolar?

Victoire Cartier1, Jérôme Boursier2,3, Jérôme Lebigot1, Frédéric Oberti2,3, Isabelle Fouchard-Hubert2,3, Christophe Aubé1,3.   

Abstract

BACKGROUND AND AIMS: Thermo-ablation by radiofrequency is recognized as a curative treatment for early-stage hepatocellular carcinoma. However, local recurrence may occur because of incomplete peripheral tumor destruction. Multipolar radiofrequency has been developed to increase the size of the maximal ablation zone. We aimed to compare the efficacy of monopolar and multipolar radiofrequency for the treatment of hepatocellular carcinoma and determine factors predicting failure.
METHODS: A total of 171 consecutive patients with 214 hepatocellular carcinomas were retrospectively included. One hundred fifty-eight tumors were treated with an expandable monopolar electrode and 56 with a multipolar technique using several linear bipolar electrodes. Imaging studies at 6 weeks after treatment, then every 3 months, assessed local effectiveness. Radiofrequency failure was defined as persistent residual tumor after two sessions (primary radiofrequency failure) or local tumor recurrence during follow-up. This study received institutional review board approval (number 2014/77).
RESULTS: Imaging showed complete tumor ablation in 207 of 214 lesions after the first session of radiofrequency. After a second session, only two cases of residual viable tumor were observed. During follow-up, there were 46 local tumor recurrences. Thus, radiofrequency failure occurred in 48/214 (22.4%) cases. By multivariate analysis, technique (P < 0.001) and tumor size (P = 0.023) were independent predictors of radiofrequency failure. Failure rate was lower with the multipolar technique for tumors < 25 mm (P = 0.023) and for tumors between 25 and 45 mm (P = 0.082). There was no difference for tumors ≥ 45 mm (P = 0.552).
CONCLUSIONS: Compared to monopolar radiofrequency, multipolar radiofrequency improves tumor ablation with a subsequent lower rate of local tumor recurrence.
© 2015 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  hepatocellular carcinoma; local tumor recurrence; multipolar radiofrequency

Mesh:

Year:  2016        PMID: 26414644     DOI: 10.1111/jgh.13179

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

1.  Transarterial chemoembolization for early stage hepatocellular carcinoma decrease local tumor control and overall survival compared to radiofrequency ablation.

Authors:  Arnaud Hocquelet; Olivier Seror; Jean-Frédéric Blanc; Nora Frulio; Cécile Salut; Jean-Charles Nault; Hervé Trillaud
Journal:  Oncotarget       Date:  2017-05-09

2.  Comparison of switching bipolar ablation with multiple cooled wet electrodes and switching monopolar ablation with separable clustered electrode in treatment of small hepatocellular carcinoma: A randomized controlled trial.

Authors:  Won Chang; Jeong Min Lee; Dong Ho Lee; Jeong Hee Yoon; Yoon Jun Kim; Jung Hwan Yoon; Joon Koo Han
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

Review 3.  Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery.

Authors:  Shuichiro Shiina; Koki Sato; Ryosuke Tateishi; Motonori Shimizu; Hideko Ohama; Takeshi Hatanaka; Masashi Takawa; Hiroaki Nagamatsu; Yasuharu Imai
Journal:  Can J Gastroenterol Hepatol       Date:  2018-06-03

4.  Neuropathologic damage induced by radiofrequency ablation at different temperatures.

Authors:  Yu Dong; Ying Chen; Baoguo Yao; Peng Song; Ruiting Xu; Rui Li; Ping Liu; Yu Zhang; Li Mu; Xin Tong; Linwei Ma; Jianjun Yu; Li Su
Journal:  Clinics (Sao Paulo)       Date:  2022-04-15       Impact factor: 2.898

5.  HabibTM 4X-assisted resection versus clamp-crush resection for hepatocellular carcinoma: a propensity-matching study.

Authors:  Jiliang Qiu; Weiqun Lu; Nanrong Yu; Guohua Yang; Yi Li; Zhiliang Huang; Jianchang Li; Kefei Li; Houwei Xu; Shicai Chen; Xiang Zeng; Haiying Liu
Journal:  Oncotarget       Date:  2017-01-17

Review 6.  Radiofrequency ablation in the management of primary hepatic and biliary tumors.

Authors:  Richard Hendriquez; Tara Keihanian; Jatinder Goyal; Rtika R Abraham; Rajnish Mishra; Mohit Girotra
Journal:  World J Gastrointest Oncol       Date:  2022-01-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.